Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Biorxiv : the Preprint Server for Biology|August 9, 2020
A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccineWeina Sun, Stephen McCroskery, Wen-Chun Liu, et al.
Microbiology Spectrum|June 6, 2022
Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in MiceIrene González-Domínguez, Jose Luis Martínez, Stefan Slamanig, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2022
Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in miceIrene González-Domínguez, Jose Luis Martínez, Stefan Slamanig, et al.
NPJ Vaccines|December 17, 2019
Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohortsRaffael Nachbagauer, Bruno Salaun, Daniel Stadlbauer, et al.
NPJ Vaccines|November 21, 2025
Immunogenicity and efficacy of homologous and heterologous NDV and MVA SARS-CoV-2 vaccines in mice and hamstersPatricia Pérez, Kaijun Jiang, Irene González-Domínguez, et al.
Medrxiv : the Preprint Server for Health Sciences|September 5, 2025
Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG and BA.3.2 following KP.2 monovalent mRNA vaccinationAnass Abbad, Brian Lerman, Jordan Ehrenhaus, et al.
Ebiomedicine|June 7, 2024
Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female miceStefan Slamanig, Irene González-Domínguez, Lauren A Chang, et al.
NPJ Vaccines|September 19, 2024
Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunityRaveen Rathnasinghe, Lauren A Chang, Rebecca Pearl, et al.
Pageof 8